Elsevier, The Lancet Public Health, Volume 4, October 2019
We read with great interest the Correspondence by Zelalem Temesgen and colleagues published in the August issue of The Lancet Public Health.1 We strongly agree that the adoption of innovative technology such as whole-genome sequencing can improve tuberculosis treatment and management. We have used whole-genome sequencing to address disparate rates of tuberculosis in New Zealand.